Market Cap : 8.59 M | Enterprise Value : 8.46 M | P/E (TTM) : | P/B : |
---|
OTCPK:ICOTF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OTCPK:ICOTF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. iCo Therapeutics's YoY EBITDA Growth for the quarter that ended in Sep. 2020 was 66.67%.
iCo Therapeutics's EBITDA per Share for the three months ended in Sep. 2020 was $-0.00.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.
iCo Therapeutics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2019 is calculated as:
YoY EBITDA Growth (A: Dec. 2019 ) | |||||
= | (EBITDA per Share (A: Dec. 2019 ) | - | EBITDA per Share (A: Dec. 2018 )) | / | | EBITDA per Share (A: Dec. 2018 ) | |
= | (-0.012 | - | -0.015) | / | | -0.015 | |
= | 20.00 % |
iCo Therapeutics's YoY EBITDA Growth for the quarter that ended in Sep. 2020 is calculated as:
YoY EBITDA Growth (Q: Sep. 2020 ) | |||||
= | (EBITDA per Share (Q: Sep. 2020 ) | - | EBITDA per Share (Q: Sep. 2019 )) | / | | EBITDA per Share (Q: Sep. 2019 )) | |
= | (-0.001 | - | -0.003) | / | | -0.003 | |
= | 66.67 % |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline